Skip to content
Search

Latest Stories

'Pharmacies could support NHS plan on future of vaccination services with additional remuneration'

In its response to NHS England's consultation on 'the future of vaccination services’, the Pharmaceutical Services Negotiating Committee (PSNC) has suggested that a wider range of NHS vaccinations being available from community pharmacies could support the achievement of increased vaccination levels.

PSNC said: “Any additional services that contractors could provide can only be considered with additional remuneration above the current global sum in the community pharmacy contractual framework to ensure that the services are adequately resourced.”


Alastair Buxton, director of NHS Services at PSNC, said: “We’ve always known, and the evidence supports this, that community pharmacies are one of the most popular and accessible places for people to receive a range of vaccinations.

“The NHS was slow to take advantage of this at the start of the Covid-19 pandemic, so we welcome this consultation from them to bring together a wide range of views on the topic.

“In the longer-term, if the right funding and support is in place, many pharmacies could help deliver a much wider range of NHS vaccination programmes – giving the public the convenience and service that they want, and taking pressure off our general practice colleagues. It makes perfect sense, and we look forward to the NHS response to this consultation.”

The consultation is designed to help NHS England deliver a future vaccination strategy. It aims to support local teams that plan and deliver vaccinations to build on the NHS COVID-19 vaccination programme’s success and learning; and provide responsive, accessible, convenient and high quality NHS vaccination services to people and their families.

The PSNC response highlights the following:

  • Community pharmacy contractors take a responsive approach to the needs of local communities, by providing access to services across opening hours that are generally longer than those in other parts of primary care;
  • The sector has shown the ability to step up in times of need and to provide surge capacity in the provision of clinical services;
  • Opportunities for distributing centrally procured vaccines to pharmacies could be explored through contracts with pharmaceutical wholesalers;
  • Enabling the increasing use of interoperable IT systems would support wider levels of vaccination through pharmacies and provide NHS England with real-time data;
  • The use of national protocols to authorise the administration of vaccines, using a team-based approach beneficially maximises the provider’s use of skill mix;
  • The use a National Enhanced Service for the commissioning of pharmacy vaccination services could support some national standardisation, where it is helpful and appropriate, while allowing local decisions on the best placed pharmacies to meet the needs of the local population;
  • A range of vaccinations available from a well distributed network of NHS providers, such as community pharmacy, will help to drive improved uptake; and
  • Pharmacy’s location at the heart of local communities means they are in a strong position to reach out to the less well-served members of the public living in their area.

More For You

Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair

Olivier Picard steps up as NPA chair, Basra as vice-chair

Olivier Picard named new NPA chair

The National Pharmacy Association (NPA) has announced Olivier Picard as the organisation’s new chair.

Picard replaces Nick Kaye whose term comes to an end this week.

Keep ReadingShow less
 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less
US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less